BD insulin syringe with BD Ultra-Fine™ 6mm™ needle
Choose the syringe that makes a difference they can feel
- Overview
- EIFU & Resources
The BD insulin syringe with the BD Ultra-Fine™ 6mm™ needle features our shortest insulin syringe needle, at 53% shorter than the 12.7-mm needle.
In a 2010 study, 80% of patients preferred shorter needles compared to 8-mm and 12.7-mm needles.2 They also more reliably deliver insulin into the subcutaneous tissue, reducing the risk of painful intramuscular (IM) injection.3
Four barrel sizes
The insulin syringe comes in four different barrel sizes and scale capacities to optimise dose.
Reduced risk of hypoglycemia
Longer needle lengths may lead to frequent IM vs subcutaneous tissue injections, which may cause unexplained hypoglycemia.1,3
BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.
- Berard L, Desrochers F, Hagerty D, et al. FIT Forum for Injection Technique Canada: Recommendations for best practices in injection technique. http://www.fit4diabetes.com/canada-english/ Updated March 2017. Accessed September 8, 2017.
- Answers & Insights Market Research. Insulin syringe test (Project Pearl). Published September 10, 2010. Accessed May 25, 2017.
- Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26(6):1519-1530.
